Genetic Predisposition to Hyperhomocysteinemia: Deficiency of Methylenetetrahydrofolate Reductase (MTHFR)
- 1 June 1997
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 78 (01) , 523-526
- https://doi.org/10.1055/s-0038-1657581
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Homocysteine and Risk of Premature Coronary Heart DiseaseCirculation, 1996
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese populationAtherosclerosis, 1996
- Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on ThrombosisNew England Journal of Medicine, 1996
- Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine ConcentrationsCirculation, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifidaThe Lancet, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?Metabolism, 1994
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994